| |
| |
|
| Insider
Information: |
Hillsberg Sanford |
| Relationship: |
Director |
| City: |
Bala Cynwyd |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,214,950 |
|
|
Indirect Shares
|
234,647 |
|
|
| Direct
Value |
$80,300 |
|
|
|
Indirect Value
|
$1,008,480 |
|
|
| Total
Shares |
3,449,597 |
|
|
| Total
Value |
$1,088,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cordex Pharma Inc |
CDXP |
10% Owner |
2007-01-04 |
3,158,000 |
2007-01-04 |
49,200 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
56,950 |
2014-02-03 |
85,447 |
Premium* |
|
|
Iovance Biotherapeutics Inc |
IOVA |
Director |
|
0 |
2016-08-25 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDXP |
Cordex Pharma Inc |
10% Owner |
– – • |
2006-08-02 |
4 |
S |
$0.11 |
$770 |
D/D |
(7,000) |
3,244,100 |
0 |
- |
|
| CDXP |
Cordex Pharma Inc |
10% Owner |
– – • |
2006-08-03 |
4 |
S |
$0.11 |
$792 |
D/D |
(7,200) |
3,236,900 |
0 |
- |
|
| CDXP |
Cordex Pharma Inc |
10% Owner |
– – • |
2006-09-06 |
4 |
S |
$0.10 |
$1,704 |
D/D |
(16,400) |
3,220,500 |
|
- |
|
| CDXP |
Cordex Pharma Inc |
10% Owner |
– – • |
2006-10-23 |
4 |
S |
$0.09 |
$4,500 |
D/D |
(50,000) |
3,170,500 |
0 |
- |
|
| CDXP |
Cordex Pharma Inc |
10% Owner |
– – • |
2007-01-04 |
4 |
S |
$0.05 |
$563 |
D/D |
(12,500) |
3,158,000 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2010-03-26 |
4 |
S |
$5.66 |
$141,500 |
D/D |
(25,000) |
6,000 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-17 |
4 |
S |
$6.93 |
$1,385,000 |
I/I |
(200,000) |
110,447 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-30 |
4 |
S |
$5.41 |
$1,352,500 |
D/D |
(250,000) |
17,974 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Director |
– • – |
2015-05-06 |
4 |
S |
$10.00 |
$500,000 |
I/I |
(50,000) |
219,000 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Director |
– • – |
2015-08-03 |
4 |
S |
$8.15 |
$264,875 |
I/I |
(32,500) |
186,500 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Director |
– • – |
2015-09-04 |
4 |
S |
$6.84 |
$109,440 |
I/I |
(16,000) |
170,500 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Director |
– • – |
2015-09-08 |
4 |
S |
$7.13 |
$117,645 |
I/I |
(16,500) |
154,000 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Director |
– • – |
2016-08-22 |
4 |
S |
$9.11 |
$491,740 |
I/I |
(54,000) |
100,000 |
0 |
- |
|
63 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
